Innodata Inc. (INOD)

ASLAN Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,375	1,146	234	81	161	131
Market Cap Growth	281.33%	390.42%	187.89%	-49.50%	22.58%	351.70%
Enterprise Value	1,320	1,124	224	74	143	120
Last Close Price	43.18	39.52	8.14	2.96	5.92	5.30
PE Ratio	33.72	39.99	-	-	-	212.54
PS Ratio	5.78	6.72	2.69	1.03	2.30	2.25
PB Ratio	15.86	18.08	9.35	4.50	6.09	5.00
P/TBV Ratio	19.45	23.82	23.68	19.29	9.22	7.51
P/FCF Ratio	38.12	42.02	689.37	-	205.30	30.89
P/OCF Ratio	31.39	32.73	39.59	-	31.21	23.17
PEG Ratio	-	14.09	14.09	14.09	14.09	14.09
EV/Sales Ratio	5.78	6.59	2.58	0.94	2.05	2.07
EV/EBITDA Ratio	31.17	42.20	76.80	-	-	47.26
EV/EBIT Ratio	33.11	46.18	249.20	-	-	154.28
EV/FCF Ratio	36.58	41.21	660.13	-	182.52	28.34
Debt / Equity Ratio	0.05	0.07	0.22	0.26	0.24	0.29
Debt / EBITDA Ratio	0.10	0.17	1.23	-	3.94	1.56
Debt / FCF Ratio	0.12	0.17	16.17	-	8.06	1.77
Asset Turnover	2.30	1.97	1.62	1.47	1.20	1.09
Quick Ratio	2.67	1.90	1.23	0.95	1.42	1.51
Current Ratio	2.87	2.05	1.40	1.14	1.59	1.74
Return on Equity (ROE)	74.32%	64.89%	-4.13%	-54.01%	-6.86%	2.66%
Return on Assets (ROA)	25.09%	17.60%	1.04%	-12.20%	-1.77%	0.91%
Return on Capital (ROIC)	40.11%	30.88%	2.11%	-23.59%	-3.10%	1.53%
Return on Capital Employed (ROCE)	40.90%	32.90%	2.50%	-	-	2.00%
Earnings Yield	3.10%	2.50%	-0.39%	-14.70%	-1.04%	0.47%
FCF Yield	2.62%	2.38%	0.14%	-9.54%	0.49%	3.24%
Buyback Yield / Dilution	-8.96%	-14.38%	-3.13%	-2.43%	-4.13%	0.78%

Updated May 9, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q